Mark Wilson, PhD
Executive Director, Inflammation
Amgen
After enjoying 7 years at Genentech, ICIS Industry Member, Mark Wilson has moved from Genentech (Distinguished Scientist) to Amgen, (Executive Director), only a few blocks down the road in South San Francisco. Dr. Wilson, who is always open to discussing and sharing his career and experience in industry, co-chaired the following session at Cytokines 2023, and was joined by a rich array of old and new colleagues in beautiful Athens. Catch up with him at Cyokines 2024 in Seoul, Korea.Â
Cytokines 2023 in Athens, Wednesday, 18 October
11:00 – 12:30 Symposium 12: Cytokines in neuro-immune interactions, inflammation and repair supported by an Unrestricted Grant from Genentech
Co-Chairs: Mark Wilson and Sandra Nicholson
11:00 – 11:25 IL-27: from parasites to mRNA vaccines, Christopher Hunter, School of Veterinary Medicine, University of Pennsylvania, USA
11:25 – 11:50 Neural pathways in the regulation of tissue inflammation and repair, Sophie Ugolini, Centre d’Immunologie de Marseille-Luminy, France
11:50 – 12:03 Beyond the Barriers: Delving into Interferon Lambda’s Role in the Brain, Effrosyni Koronaiou, Biomedical Research Foundation Of The Academy Of Athens, Greece
12:03 – 12:16 Influence of the Chemokines CCL17 and CCL22 on IL-33-induced Adipose Tissue Fibrosis, Manja Thiem, LIMES Institute, University of Bonn, Germany
12:16 – 12:29 MAVS signaling in microglia is critically needed to define the transcriptional fate of CNS infiltrating CD8+ T cells in viral encephalitis, Andreas Pavlou, Twincore, Germany
